Similar articles for PMID: 32859636

Year	Number of Results
1998	1
2006	1
2007	1
2008	1
2011	6
2012	3
2013	3
2014	6
2015	12
2016	12
2017	11
2018	10
2019	9
2020	11
2021	1
2022	1

1

Expression Patterns of CD44 and AREG Under Treatment With Selective Tyrosine Kinase Inhibitors in HPV⁺ and HPV^- Squamous Cell Carcinoma.

Kansy B, Aderhold C, Huber L, Ludwig S, Birk R, Lammert A, Lang S, Rotter N, Kramer B. Kansy B, et al. Cancer Genomics Proteomics. 2020 Sep-Oct;17(5):579-585. doi: 10.21873/cgp.20214. Cancer Genomics Proteomics. 2020. PMID: 32859636 Free PMC article.

2

Tyrosine Kinase Inhibition in HPV-related Squamous Cell Carcinoma Reveals Beneficial Expression of cKIT and Src.

Kramer B, Kneissle M, Birk R, Rotter N, Aderhold C. Kramer B, et al. Anticancer Res. 2018 May;38(5):2723-2731. doi: 10.21873/anticanres.12514. Anticancer Res. 2018. PMID: 29715092

3

Targeting mTOR and AREG with everolimus, sunitinib and sorafenib in HPV-positive and -negative SCC.

Aderhold C, Faber A, Umbreit C, Birk R, Weiss C, Sommer JU, Hörmann K, Schultz JD. Aderhold C, et al. Anticancer Res. 2015 Apr;35(4):1951-9. Anticancer Res. 2015. PMID: 25862847

4

Targeted Therapies in HPV-positive and -negative HNSCC - Alteration of EGFR and VEGFR-2 Expression In Vitro.

Kramer B, Hock C, Birk R, Sauter A, Stuck BA, Hörmann K, Schultz JD, Aderhold C. Kramer B, et al. Anticancer Res. 2016 Jun;36(6):2799-807. Anticancer Res. 2016. PMID: 27272791

5

Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance.

Bourguignon LYW, Earle C, Shiina M. Bourguignon LYW, et al. Matrix Biol. 2019 May;78-79:180-200. doi: 10.1016/j.matbio.2018.07.008. Epub 2018 Aug 3. Matrix Biol. 2019. PMID: 30077625

6

Effect of Small-molecule Tyrosine Kinase Inhibitors on PDGF-AA/BB and PDGFRα/β Expression in SCC According to HPV16 Status.

Huber L, Birk R, Rotter N, Aderhold C, Lammert A, Jungbauer F, Kramer B. Huber L, et al. Anticancer Res. 2020 Feb;40(2):825-835. doi: 10.21873/anticanres.14014. Anticancer Res. 2020. PMID: 32014925

7

Tyrosine Kinase Inhibitors and Everolimus Reduce IGF1R Expression in HPV16-positive and -negative Squamous Cell Carcinoma.

Kramer B, Schell A, Aderhold C, Huber L, Mueller CE, Rotter N, Birk R. Kramer B, et al. Anticancer Res. 2020 Jul;40(7):3847-3855. doi: 10.21873/anticanres.14374. Anticancer Res. 2020. PMID: 32620624

8

FGF Expression in HPV16-positive and -negative SCC After Treatment With Small-molecule Tyrosine Kinase Inhibitors and Everolimus.

Huber L, Birk R, Knuettel M, Rotter N, Aderhold C, Scherl C, Lammert A, Jungbauer F, Kramer B. Huber L, et al. Anticancer Res. 2020 Oct;40(10):5621-5630. doi: 10.21873/anticanres.14575. Anticancer Res. 2020. PMID: 32988886

9

Impact of Small Molecules on β-Catenin and E-Cadherin Expression in HPV16-positive and -negative Squamous Cell Carcinomas.

Kramer B, Hock C, Schultz JD, Lammert A, Kuhlin B, Birk R, Hörmann K, Aderhold C. Kramer B, et al. Anticancer Res. 2017 Jun;37(6):2845-2852. doi: 10.21873/anticanres.11636. Anticancer Res. 2017. PMID: 28551620

10

Apoptosis-related Proteins Are Altered by Selective Tyrosine Kinase Inhibitors and Everolimus in HPV-dependent SCC.

Birk R, Schell A, Aderhold C, Hoch S, Huber L, Mueller CE, Lammert A, Scherl C, Rotter N, Sommer JU, Kramer B. Birk R, et al. Anticancer Res. 2020 Nov;40(11):6195-6203. doi: 10.21873/anticanres.14639. Anticancer Res. 2020. PMID: 33109556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed